Laura Lisicki
Payments from drug & device makers
Across 149 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$364
- Astellas Pharma US Inc$333
- Pfizer$284
- Lilly USA, LLC$257
- AstraZeneca$209
- Abbott$131
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,67298%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $364 |
| Astellas Pharma US Inc | 14 | $333 |
| Pfizer | 16 | $284 |
| Lilly USA, LLC | 15 | $257 |
| AstraZeneca(2 entities) | 12 | $209 |
| Abbott | 4 | $131 |
| Kowa Pharmaceuticals America, Inc. | 8 | $109 |
| Sanofi-aventis U.S. LLC | 8 | $107 |
| Johnson & Johnson | 6 | $99 |
| Amgen | 6 | $96 |
| Bayer | 4 | $81 |
| GSK | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Boston Scientific | 1 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Exact Sciences | 3 | $53 |
| Medtronic | 2 | $52 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Medicure Pharma Inc. | 1 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Bausch Health US, LLC | 1 | $29 |
| Almatica Pharma LLC | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Merck | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Vistapharm, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$2,738 in reported general payments places this provider in the 85th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 21 | $21,730 |
| FarxigaDapagliflozin Propanediol | 15 | $12,847 |
| XareltoRivaroxaban | 12 | $9,758 |
| Humalog Kwikpen U-100Insulin Lispro | 12 | $2,341 |
| Levothyroxine Sodium | 117 | $1,122 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $1,038 |
| Omeprazole | 72 | $1,019 |
| Atorvastatin Calcium | 78 | $1,012 |
| Rosuvastatin Calcium | 93 | $918 |
| Gabapentin | 76 | $776 |
| Bupropion XlBupropion Hcl | 24 | $684 |
| Olmesartan Medoxomil | 36 | $683 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 15 | $573 |
| Amlodipine Besylate | 68 | $550 |
| Ezetimibe | 48 | $502 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $257 | $21,73021 claims |
| AstraZenecaFarxiga | $209 | $12,84715 claims |
| Johnson & JohnsonXarelto | $99 | $9,75812 claims |
| Almatica Pharma LLCSertraline Hcl | $26 | $32730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,522 family providers in North Carolina.
Other family in Cary
- Amanda KellyCary$94K
- Daria LewisCary$66K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.